A
Agilent Technologies, Inc.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$150.98
+0.67%Forward multiples
Based on analyst estimates
- P/E forward
- 22.96x
- P/E 2026E
- 24.11x
- P/E 2027E
- 22.15x
- P/E 2028E
- 20.03x
- P/S forward
- 5.41x
Trailing multiples
Trailing twelve months
- P/E TTM
- 29.66x
- PEG TTM
- 1.01x
- Price / book
- 5.78x
- Price / sales
- 5.77x
- Price / cash flow
- 26.45x
Enterprise value
- Enterprise value
- $44.8B
- EV / sales
- 6.07x
- EV / EBITDA
- 22.73x
- EV / EBIT
- 27.31x
- Market cap
- $42.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jul 1, 2026